Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Most of what we know about BPC-157 comes from preclinical research, mainly animal studies
GHK-Cu is a research-grade copper-binding tripeptide supplied in lyophilized vial format for controlled laboratory work examining copper-associated peptide signaling and structural-response pathway models
"Copper tripeptide" and "GHK-Cu" both refer to the same molecule: glycyl-L-histidyl-L-lysine bound to a copper ion
The procedure is typically performed under local anesthesia and you can return to work in as little as 48 hours
BPC 157 and Standard Angiogenic Growth Factors Key Findings: BPC-157, when compared to standard peptidergic angiogenic growth factors (EGF, FGF, VEGF), has been effective in all models of acute/chronic injury of the gastrointestinal tract, whether administered intraperitoneally, per-orally, or locally
BPC-157 and TB-500 have distinct pharmacokinetic properties that researchers should account for when designing dosing intervals and endpoint measurements
